Universitaetsklinikum Leipzig AöR
Universitaetsklinikum Leipzig AöR is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A phase IIIb, open-label, single arm study to evaluate the efficacy and safety of luspatercept in patients with lower-risk MDS and ringsideroblastic phenotype (MDS-RS)
Sponsor GWT-Tud GmbH
- Start (EU)
- Latest update
- Estimated end
Primary comparison of Liposomal Anthracycline based treatment versus conventional care strategies prior to allogeneic stem cell transplantation in patients with higher risk MDS or oligoblastic AML
Sponsor GWT-Tud GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Multicenter, Phase Ib/IIa Study on the Safety and Efficacy of Autologous Peptide-coupled Red Blood Cells in Patients with Relapsing Remitting Multiple Sclerosis
Sponsor Cellerys AG
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Universitaetsklinikum Leipzig AöR?
The 2026-10-09 snapshot links Universitaetsklinikum Leipzig AöR to 3 distinct CTIS trials. Recorded services include Biobanking, Biobanking and translational program, Blood donation unit for site 2- 03/Leipzig/Then Bergh, Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Universitaetsklinikum Leipzig AöR?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Universitaetsklinikum Leipzig AöR conducted?
The linked trials record locations in 5 countries, including Germany, Austria, Czechia, Spain, Italy. These are trial locations, not confirmed office locations or countries where Universitaetsklinikum Leipzig AöR delivered services.
What can this page tell me about Universitaetsklinikum Leipzig AöR's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Universitaetsklinikum Leipzig AöR. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Universitaetsklinikum Leipzig AöR